President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Clinical Research50-Year Medalist Study
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowGet InvolvedEventsTributes & Special OccasionsCorporate & Foundation EngagementLegacy GivingWays to GivePhilanthropy TeamPublications

News Release

NIH Awards $9.5 Million Grant to Joslin Diabetes Center to Support Diabetes Research

BOSTON – October 3, 2012 - Joslin Diabetes Center, Boston, Massachusetts, has been awarded a $9.5 million, multi-year Diabetes Research Center (DRC) grant from the National Institutes of Diabetes, Digestive and Kidney Disorders (NIDDK) of the National Institute of Health (NIH). This marks the 26th year in which Joslin has been awarded the DRC grant.

Affiliated with Harvard Medical School, Joslin is home to the nation’s largest concentration of diabetes researchers. The wide spectrum of research at Joslin aims to discover treatments, prevention and, ultimately, a cure for both type 1 and type 2 diabetes and diabetes complications.

The Joslin DRC provides a framework to facilitate multi-disciplinary basic, translational and clinical diabetes research, to encourage the scientific development of young investigators and to foster collaborations that further diabetes research.

According to George King, M.D., Chief Scientific Officer at Joslin, “During the past 25 years, the Joslin Diabetes Center’s DRC grant has stimulated and nurtured diabetes research at Joslin and in the surrounding Harvard Medical School community.  The DRC, with its Core Laboratories, Enrichment Program, and support for the Pilot and Feasibility Program, has provided critical infrastructure for basic, translational, and clinical research, and has created an outstanding intellectual enrichment base for diabetes researchers at Joslin and across the Harvard/Longwood medical area.”

The grant will support the Joslin DRC from September 2012 to August 2017.